Copyright: ©Author(s) 2026.
World J Gastroenterol. Aug 7, 2026; 32(29): 118090
Published online Aug 7, 2026. doi: 10.3748/wjg.118090
Published online Aug 7, 2026. doi: 10.3748/wjg.118090
Figure 5 Decision curve analysis of the nomogram and Freiburg index of post-transjugular intrahepatic portosystemic shunt survival score evaluating 3-month, 6-month and 1-year net benefit.
A-C: Training cohort; D-F: Internal validation cohort; G-I: External validation cohort. Across all cohorts, the nomogram consistently achieved higher net benefits than the Freiburg index of post-transjugular intrahepatic portosystemic shunt survival scoring system over a wide range of clinical decision thresholds. FIPS: Freiburg index of post-transjugular intrahepatic portosystemic shunt survival.
- Citation: Zhang JQ, Yin L, Zhu YJ, Dong L, Hou CL, Tian SJ, Chen P, Huang XZ, Xu H, Chen ZY, Xu XJ, Zhou CZ, Cheng DL. Modified model incorporating sarcopenia and myosteatosis for predicting severe hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: Multicenter study. World J Gastroenterol 2026; 32(29): 118090
- URL: https://www.wjgnet.com/1007-9327/full/v32/i29/118090.htm
- DOI: https://dx.doi.org/10.3748/wjg.118090